相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
Kate Young et al.
GUT (2021)
Alterations in Ki67 Labeling Following Treatment of Poorly Differentiated Neuroendocrine Carcinomas A Potential Diagnostic Pitfall
Monika Vyas et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors
Johan Botling et al.
NEUROENDOCRINOLOGY (2020)
PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Halfdan Sorbye et al.
ENDOCRINE-RELATED CANCER (2020)
A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial)
Hiroyuki Okuyama et al.
NEUROENDOCRINOLOGY (2020)
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y
M. Pavel et al.
ANNALS OF ONCOLOGY (2020)
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
Alberto Puccini et al.
CLINICAL CANCER RESEARCH (2020)
Pancreatic neuroendocrine carcinoma G3 may be heterogeneous and could be classified into two distinct groups
Hiroki Tanaka et al.
PANCREATOLOGY (2020)
Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients
Jingjing Zhang et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia
Frediano Inzani et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
Sunitinib shrinks NET-G3 pancreatic neuroendocrine neoplasms
Yuki Mizuno et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study
Susumu Hijioka et al.
CLINICAL CANCER RESEARCH (2017)
Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumours
Joakim Crona et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
M. Pavel et al.
NEUROENDOCRINOLOGY (2016)
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
R. Garcia-Carbonero et al.
NEUROENDOCRINOLOGY (2016)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
Are G3 ENETS neuroendocrine neoplasms heterogeneous?
Fritz-Line Velayoudom-Cephise et al.
ENDOCRINE-RELATED CANCER (2013)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)